These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

313 related items for PubMed ID: 14519641

  • 1. Thymidylate synthase expression predicts the response to 5-fluorouracil-based adjuvant therapy in pancreatic cancer.
    Hu YC, Komorowski RA, Graewin S, Hostetter G, Kallioniemi OP, Pitt HA, Ahrendt SA.
    Clin Cancer Res; 2003 Sep 15; 9(11):4165-71. PubMed ID: 14519641
    [Abstract] [Full Text] [Related]

  • 2. Predictive role of thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase expression in colorectal cancer patients receiving adjuvant 5-fluorouracil.
    Ciaparrone M, Quirino M, Schinzari G, Zannoni G, Corsi DC, Vecchio FM, Cassano A, La Torre G, Barone C.
    Oncology; 2006 Sep 15; 70(5):366-77. PubMed ID: 17179731
    [Abstract] [Full Text] [Related]

  • 3. Thymidylate synthase and dihydropyrimidine dehydrogenase mRNA expression levels: predictors for survival in colorectal cancer patients receiving adjuvant 5-fluorouracil.
    Kornmann M, Schwabe W, Sander S, Kron M, Sträter J, Polat S, Kettner E, Weiser HF, Baumann W, Schramm H, Häusler P, Ott K, Behnke D, Staib L, Beger HG, Link KH.
    Clin Cancer Res; 2003 Sep 15; 9(11):4116-24. PubMed ID: 14519634
    [Abstract] [Full Text] [Related]

  • 4. Thymidylate synthase, thymidine phosphorylase, dihydropyrimidine dehydrogenase expression, and histological tumour regression after 5-FU-based neo-adjuvant chemoradiotherapy in rectal cancer.
    Jakob C, Aust DE, Meyer W, Baretton GB, Schwabe W, Häusler P, Becker H, Liersch T.
    J Pathol; 2004 Dec 15; 204(5):562-8. PubMed ID: 15538739
    [Abstract] [Full Text] [Related]

  • 5. [Pharmacogenetic studies on the prediction of efficacy and toxicity of fluoropyrimidine-based adjuvant therapy in colorectal cancer].
    Kralovánszky J, Adleff V, Hitre E, Pap E, Réti A, Komlósi V, Budai B.
    Magy Onkol; 2007 Dec 15; 51(2):113-25. PubMed ID: 17660867
    [Abstract] [Full Text] [Related]

  • 6. Thymidylate synthase was associated with patient prognosis and the response to adjuvant therapy in bladder cancer.
    Li Y, Li X, Dai H, Sun X, Li J, Yang F, Gu H, Yang Y, Jin Z, Chu Y, Jin X, Kakehi Y, Wu X.
    BJU Int; 2009 Feb 15; 103(4):547-52. PubMed ID: 18990150
    [Abstract] [Full Text] [Related]

  • 7. Prognostic and predictive value of the thymidylate synthase expression in patients with non-metastatic colorectal cancer.
    Aguiar S, Lopes A, Soares FA, Rossi BM, Ferreira FO, Nakagawa WT, Carvalho AL, Filho WJ.
    Eur J Surg Oncol; 2005 Oct 15; 31(8):863-8. PubMed ID: 15923105
    [Abstract] [Full Text] [Related]

  • 8. Expression of thymidylate synthase in gastric cancer patients treated with 5-fluorouracil and doxorubicin-based adjuvant chemotherapy after curative resection.
    Choi J, Lim H, Nam DK, Kim HS, Cho DY, Yi JW, Kim HC, Cho YK, Kim MW, Joo HJ, Lee KB, Kim KB.
    Br J Cancer; 2001 Jan 15; 84(2):186-92. PubMed ID: 11161374
    [Abstract] [Full Text] [Related]

  • 9. Tumor thymidylate synthase 1494del6 genotype as a prognostic factor in colorectal cancer patients receiving fluorouracil-based adjuvant treatment.
    Dotor E, Cuatrecases M, Martínez-Iniesta M, Navarro M, Vilardell F, Guinó E, Pareja L, Figueras A, Molleví DG, Serrano T, de Oca J, Peinado MA, Moreno V, Germà JR, Capellá G, Villanueva A.
    J Clin Oncol; 2006 Apr 01; 24(10):1603-11. PubMed ID: 16575011
    [Abstract] [Full Text] [Related]

  • 10. Immunohistochemical evaluation of thymidylate synthase (TS) and p16INK4a in advanced colorectal cancer: implication of TS expression in 5-FU-based adjuvant chemotherapy.
    Kamoshida S, Matsuoka H, Ishikawa T, Maeda K, Shimomura R, Inada K, Tsutsumi Y.
    Jpn J Clin Oncol; 2004 Oct 01; 34(10):594-601. PubMed ID: 15591457
    [Abstract] [Full Text] [Related]

  • 11. Thymidylate synthase gene polymorphism predicts toxicity in colorectal cancer patients receiving 5-fluorouracil-based chemotherapy.
    Lecomte T, Ferraz JM, Zinzindohoué F, Loriot MA, Tregouet DA, Landi B, Berger A, Cugnenc PH, Jian R, Beaune P, Laurent-Puig P.
    Clin Cancer Res; 2004 Sep 01; 10(17):5880-8. PubMed ID: 15355920
    [Abstract] [Full Text] [Related]

  • 12. Lymph node status and TS gene expression are prognostic markers in stage II/III rectal cancer after neoadjuvant fluorouracil-based chemoradiotherapy.
    Liersch T, Langer C, Ghadimi BM, Kulle B, Aust DE, Baretton GB, Schwabe W, Häusler P, Becker H, Jakob C.
    J Clin Oncol; 2006 Sep 01; 24(25):4062-8. PubMed ID: 16943523
    [Abstract] [Full Text] [Related]

  • 13. Intratumoral expression of thymidylate synthase and dihydropyrimidine dehydrogenase in non-small cell lung cancer patients treated with 5-FU-based chemotherapy.
    Huang CL, Yokomise H, Kobayashi S, Fukushima M, Hitomi S, Wada H.
    Int J Oncol; 2000 Jul 01; 17(1):47-54. PubMed ID: 10853017
    [Abstract] [Full Text] [Related]

  • 14. Intratumoural expression of thymidylate synthase is an independent predictor of prognosis in patients with squamous cell carcinoma of the tongue: results from a retrospective study.
    Kawano K, Yanagisawa S, Kusukawa J, Sunagawa H, Shiba R, Goto M, Shinohara M, Fukuda J, Oishi M, Ikemura K, Takahashi T, Sugihara K, Inokuchi T, Mimura T, Goto H.
    Int J Oral Maxillofac Surg; 2006 Mar 01; 35(3):258-64. PubMed ID: 16280240
    [Abstract] [Full Text] [Related]

  • 15. Prognostic value of 5-fluorouracil metabolic enzyme genes in Dukes' stage B and C colorectal cancer patients treated with oral 5-fluorouracil-based adjuvant chemotherapy.
    Yamada H, Iinuma H, Watanabe T.
    Oncol Rep; 2008 Mar 01; 19(3):729-35. PubMed ID: 18288408
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Do thymidylate synthase gene promoter polymorphism and the C/G single nucleotide polymorphism predict effectiveness of adjuvant 5-fluorouracil-based chemotherapy in stage III colonic adenocarcinoma?
    Prall F, Ostwald C, Schiffmann L, Barten M.
    Oncol Rep; 2007 Jul 01; 18(1):203-9. PubMed ID: 17549369
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Thymidylate synthase expression pattern is a prognostic factor in patients of colorectal cancer treated with 5-fluorouracil.
    Fernández-Contreras ME, Jiménez De Ayala B, García De Paredes ML, Velasco A, Majano PL, Palacios J, Gamallo C.
    Int J Oncol; 2004 Oct 01; 25(4):877-85. PubMed ID: 15375535
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.